Russian government tasked to saturate domestic market with its own drugs
19 May 2014
“Our target is to start producing 90% of these essential medications inside the country till 2018,” the prime minister Dmitry Medvedev said
18 May 2014
Russian Prime Minister Dmitry Medvedev called a pharmaceutical community not only to manufacture vital drugs but to develop them locally.
18 May 2014
Russian Prime Minister Dmitry Medvedev entrusted Russian Ministry of Economic Development and Export Insurance Agency of Russia (EXIAR) to draft proposals on the support of exporters of domestic pharmaceutical and medical products.
Proprietary super drugs will land in Russia
18 May 2014
Head of the Russian Ministry of Health told that clinical development programs of novel drugs to combat lethal diseases are underway.
Russia to stand a good chance for leading positions in the biotech field - Medvedev
18 May 2014
Russia stands a chance to take leading positions in the biotech field, Russian Prime Minister Dmitry Medvedev reckons.
State to support exporters of medical and pharmaceutical products - Medvedev
17 May 2014
Russian Prime Minister Dmitry Medvedev entrusted the Russian Ministry of Economic Development and Trade to draft proposals on facilitation of Russian exporters of medical and pharmaceutical products through the Export Insurance Agency of Russia.
LA BioMed woos deep pockets interested in its lifesaving research
06 May 2014
From iodine eyedrops that prevent blindness in children to cholesterol testing to early discoveries that led to in vitro fertilization, the Los Angeles Biomedical Research Institute has made innovative scientific breakthroughs with worldwide implications since 1962.
Surgeon reports high patient satisfaction with hydrogel corneal inlay
06 May 2014
Overall patient satisfaction is 98% after implantation with the Raindrop inlay, according to a surgeon here.
Angel Investors Look At Biotech
05 May 2014
Angel groups are investing in biotech and are staying involved longer than ever before, creating new collaborations and financing options that raise more money than initial and subsequent rounds. Some say that today’s angels are similar to venture capitalists in the early 1990s.
Less is more for VCs investing in biotech
21 April 2014
Even in an off-quarter, biotech showed itself to be a key driver of New York's growing tech sector, and that momentum will need to continue in the face of stiff market headwinds.
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
2024 drug approvals: Small companies loom large with several key FDA nods
13 January 2025
Special Regulations for Foreign-Packaged Medicines Extended Until the End of 2025
13 January 2025
Russia Begins Production of Terbium-161 Isotope for Cancer Therapy
10 January 2025
FMBA has begun clinical trials of a vaccine against five serotypes of meningococcus
10 January 2025